BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25359730)

  • 1. Elimination of cancer stem-like side population in human glioblastoma cells accompanied with stemness gene suppression by Korean herbal recipe MSC500.
    Yao CJ; Han TY; Shih PH; Yi TY; Lai IC; Chang KH; Lai TY; Chang CL; Lai GM
    Integr Cancer Ther; 2014 Nov; 13(6):541-54. PubMed ID: 25359730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of cancer stem-like cells and potentiation of temozolomide sensitivity by Honokiol in glioblastoma multiforme cells.
    Lai IC; Shih PH; Yao CJ; Yeh CT; Wang-Peng J; Lui TN; Chuang SE; Hu TS; Lai TY; Lai GM
    PLoS One; 2015; 10(3):e0114830. PubMed ID: 25763821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells.
    Colamaio M; Tosti N; Puca F; Mari A; Gattordo R; Kuzay Y; Federico A; Pepe A; Sarnataro D; Ragozzino E; Raia M; Hirata H; Gemei M; Mimori K; Del Vecchio L; Battista S; Fusco A
    Expert Opin Ther Targets; 2016 Oct; 20(10):1169-79. PubMed ID: 27486901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
    Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
    Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.
    Jin X; Jeon HY; Joo KM; Kim JK; Jin J; Kim SH; Kang BG; Beck S; Lee SJ; Kim JK; Park AK; Park WY; Choi YJ; Nam DH; Kim H
    Cancer Res; 2011 Apr; 71(8):3066-75. PubMed ID: 21363911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte Elevated Gene-1 Regulates β-Catenin Signaling to Maintain Glioma Stem-like Stemness and Self-Renewal.
    Hu B; Emdad L; Kegelman TP; Shen XN; Das SK; Sarkar D; Fisher PB
    Mol Cancer Res; 2017 Feb; 15(2):225-233. PubMed ID: 27903708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram.
    Triscott J; Rose Pambid M; Dunn SE
    Stem Cells; 2015 Apr; 33(4):1042-6. PubMed ID: 25588723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and molecular characterization of glioblastoma multiforme-derived cancer stem cells.
    Tomuleasa C; Soritau O; Rus-Ciuca D; Ioani H; Susman S; Petrescu M; Timis T; Cernea D; Kacso G; Irimie A; Florian IS
    J BUON; 2010; 15(3):583-91. PubMed ID: 20941832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Korean Red ginseng extract inhibits glioblastoma propagation by blocking the Wnt signaling pathway.
    Ham SW; Kim JK; Jeon HY; Kim EJ; Jin X; Eun K; Park CG; Lee SY; Seo S; Kim JY; Choi SH; Hong N; Lee YY; Kim H
    J Ethnopharmacol; 2019 May; 236():393-400. PubMed ID: 30878548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
    Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
    Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cDNA-microarray analysis of camptothecin resistance in glioblastoma cell lines.
    Morandi E; Zingaretti C; Chiozzotto D; Severini C; Semeria A; Horn W; Vaccari M; Serra R; Silingardi P; Colacci A
    Cancer Lett; 2006 Jan; 231(1):74-86. PubMed ID: 16356833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays.
    Warrier S; Pavanram P; Raina D; Arvind M
    Cell Biol Int; 2012; 36(12):1137-43. PubMed ID: 22770475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairing temozolomide resistance driven by glioma stem-like cells with adjuvant immunotherapy targeting O-acetyl GD2 ganglioside.
    Fleurence J; Bahri M; Fougeray S; Faraj S; Vermeulen S; Pinault E; Geraldo F; Oliver L; Véziers J; Marquet P; Rabé M; Gratas C; Vallette F; Pecqueur C; Paris F; Birklé S
    Int J Cancer; 2020 Jan; 146(2):424-438. PubMed ID: 31241171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview.
    Chu PM; Ma HI; Chen LH; Chen MT; Huang PI; Lin SZ; Chiou SH
    Cell Transplant; 2013; 22(4):741-53. PubMed ID: 23127968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of side population cells isolated from the colon cancer cell line SW480.
    Xiong B; Ma L; Hu X; Zhang C; Cheng Y
    Int J Oncol; 2014 Sep; 45(3):1175-83. PubMed ID: 24926880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1.
    Fukaya R; Ohta S; Yamaguchi M; Fujii H; Kawakami Y; Kawase T; Toda M
    Cancer Lett; 2010 May; 291(2):150-7. PubMed ID: 19913993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
    Yang YP; Chang YL; Huang PI; Chiou GY; Tseng LM; Chiou SH; Chen MH; Chen MT; Shih YH; Chang CH; Hsu CC; Ma HI; Wang CT; Tsai LL; Yu CC; Chang CJ
    J Cell Physiol; 2012 Mar; 227(3):976-93. PubMed ID: 21503893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.